help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HILL, A. T.
Right arrow Articles by STOCKLEY, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HILL, A. T.
Right arrow Articles by STOCKLEY, R. A.

Am. J. Respir. Crit. Care Med., Volume 160, Number 3, September 1999, 893-898

The Interrelationship of Sputum Inflammatory Markers in Patients with Chronic Bronchitis

ADAM T. HILL, DARREN BAYLEY, and ROBERT A. STOCKLEY

Department of Medicine, Queen Elizabeth Hospital, Birmingham, United Kingdom

Many of the features of bronchial disease are believed to be caused by damage to the airways by elastase released by recruited neutrophils. There have been few studies of the mechanisms involved and the interrelationships between components of the inflammatory process. We studied secretions from patients with chronic bronchitis in the stable state. We assessed the presence of neutrophils by measuring myeloperoxidase (MPO) activity and active neutrophil elastase (NE). These results were compared with the chemoattractants interleukin-8 (IL-8) and leukotriene B4 (LTB4), the bronchial inhibitor secretory leukoprotease inhibitor (SLPI), and protein leak (sputum/serum albumin ratio). MPO correlated with NE activity (r = 0.68, p < 0.001) and both IL-8 (r = 0.52, p < 0.001) and LTB4 (r = 0.41, p < 0.001) indicating an association with the chemoattractants. Elastase activity correlated with IL-8 (r = 0.55, p < 0.001) and LTB4 (r = 0.41, p < 0.001) but negatively with SLPI (r = -0.49, p < 0.001). NE also correlated positively with protein leak (r = 0.36, p < 0.001), suggesting a cause and effect. MPO and protein leak correlated negatively with FEV1 (percentage of predicted) only in patients with chronic obstructive pulmonary disease (COPD) without alpha 1-antitrypsin deficiency (r = -0.37, p < 0.001; r = -0.42, p < 0.01, respectively). These complex interactions provide a template for future studies with specific inhibitors or agonists which will clarify the role of individual factors.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J., February 1, 2008; 31(2): 416 - 469.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
T. Yamagata, H. Sugiura, T. Yokoyama, S. Yanagisawa, T. Ichikawa, K. Ueshima, K. Akamatsu, T. Hirano, M. Nakanishi, Y. Yamagata, et al.
Overexpression of CD-11b and CXCR1 on Circulating Neutrophils: Its Possible Role in COPD
Chest, September 1, 2007; 132(3): 890 - 899.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
E. J. Naylor, D. Bakstad, M. Biffen, B. Thong, P. Calverley, S. Scott, C. A. Hart, R. J. Moots, and S. W. Edwards
Haemophilus influenzae Induces Neutrophil Necrosis: A Role in Chronic Obstructive Pulmonary Disease?
Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 135 - 143.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
B. R. Celli and P. J. Barnes
Exacerbations of chronic obstructive pulmonary disease
Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. Scuri, J. R. Sabater, and W. M. Abraham
Hyaluronan blocks porcine pancreatic elastase-induced mucociliary dysfunction in allergic sheep
J Appl Physiol, June 1, 2007; 102(6): 2324 - 2331.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J. L Simpson, T. V Grissell, J. Douwes, R. J Scott, M. J Boyle, and P. G Gibson
Innate immune activation in neutrophilic asthma and bronchiectasis
Thorax, March 1, 2007; 62(3): 211 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. R. Hurst, G. C. Donaldson, W. R. Perera, T. M. A. Wilkinson, J. A. Bilello, G. W. Hagan, R. S. Vessey, and J. A. Wedzicha
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 867 - 874.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. Marian, S. Baraldo, A. Visentin, A. Papi, M. Saetta, L. M. Fabbri, and P. Maestrelli
Up-Regulated Membrane and Nuclear Leukotriene B4 Receptors in COPD
Chest, June 1, 2006; 129(6): 1523 - 1530.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R O'Donnell, D Breen, S Wilson, and R Djukanovic
Inflammatory cells in the airways in COPD
Thorax, May 1, 2006; 61(5): 448 - 454.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
E Sapey and R A Stockley
COPD exacerbations {middle dot} 2: Aetiology.
Thorax, March 1, 2006; 61(3): 250 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij
Guidelines for the management of adult lower respiratory tract infections
Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
C. A. Owen
Proteinases and Oxidants as Targets in the Treatment of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 373 - 385.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. R. Sabater, T. A. Lee, and W. M. Abraham
Comparative Effects of Salmeterol, Albuterol, and Ipratropium on Normal and Impaired Mucociliary Function in Sheep
Chest, November 1, 2005; 128(5): 3743 - 3749.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P Montuschi, F Macagno, P Parente, S Valente, L Lauriola, G Ciappi, S A Kharitonov, P J Barnes, and G Ciabattoni
Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD
Thorax, October 1, 2005; 60(10): 827 - 833.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
Y Minakata, M Nakanishi, T Hirano, K Matsunaga, T Yamagata, and M Ichinose
Microvascular hyperpermeability in COPD airways
Thorax, October 1, 2005; 60(10): 882 - 882.
[Full Text] [PDF]

Home page
 ERRHome page
P. J. Barnes
New approaches to COPD
Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
R. Buhl and S. G. Farmer
Future Directions in the Pharmacologic Therapy of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 83 - 93.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R A O'Donnell, A Richter, J Ward, G Angco, A Mehta, K Rousseau, D M Swallow, S T Holgate, R Djukanovic, D E Davies, et al.
Expression of ErbB receptors and mucins in the airways of long term current smokers
Thorax, December 1, 2004; 59(12): 1032 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. A. Mahler, S. Huang, M. Tabrizi, and G. M. Bell
Efficacy and Safety of a Monoclonal Antibody Recognizing Interleukin-8 in COPD: A Pilot Study
Chest, September 1, 2004; 126(3): 926 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Morris, F. C. Sciurba, I. P. Lebedeva, A. Githaiga, W. M. Elliott, J. C. Hogg, L. Huang, and K. A. Norris
Association of Chronic Obstructive Pulmonary Disease Severity and Pneumocystis Colonization
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 408 - 413.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P J Barnes
Chronic obstructive pulmonary disease * 12: New treatments for COPD
Thorax, September 1, 2003; 58(9): 803 - 808.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Gabrijelcic, A. Acuna, M. Profita, A. Paterno, K.F. Chung, A.M. Vignola, and R. Rodriguez-Roisin
Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression
Eur. Respir. J., August 1, 2003; 22(2): 290 - 297.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A J White, S Gompertz, D L Bayley, S L Hill, C O'Brien, I Unsal, and R A Stockley
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis
Thorax, August 1, 2003; 58(8): 680 - 685.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P Montuschi, S A Kharitonov, G Ciabattoni, and P J Barnes
Exhaled leukotrienes and prostaglandins in COPD
Thorax, July 1, 2003; 58(7): 585 - 588.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R.O. Crapo, R.L. Jensen, and F.E. Hargreave
Airway inflammation in COPD: physiological outcome measures and induced sputum
Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Mukaida
Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases
Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L566 - L577.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Inoue, H. Nakamura, K. Otake, H. Saito, K. Terashita, J. Sato, H. Takeda, and H. Tomoike
Impaired Pulmonary Inflammatory Responses Are a Prominent Feature of Streptococcal Pneumonia in Mice with Experimental Emphysema
Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 764 - 770.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
I S Woolhouse, D L Bayley, and R A Stockley
Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis
Thorax, August 1, 2002; 57(8): 667 - 671.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
I S Woolhouse, D L Bayley, and R A Stockley
Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of {alpha}1-antitrypsin deficiency and the role of leukotriene B4 and interleukin 8
Thorax, August 1, 2002; 57(8): 709 - 714.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
Leader of the Working Group: P.L. Paggiaro, Members of the Working Group:, P. Chanez, O. Holz, P.W. Ind, R. Djukanovic, P. Maestrelli, and P.J. Sterk
Sputum induction
Eur. Respir. J., July 1, 2002; 20(37_suppl): 3S - 8s.
[Full Text] [PDF]

Home page
 ThoraxHome page
R A O'Donnell and A J Frew
Is there more than one inflammatory phenotype in asthma?
Thorax, July 1, 2002; 57(7): 566 - 568.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
Leader of the Working Group: M.M. Kelly, Members of the Working Group:, V. Keatings, R. Leigh, C. Peterson, J. Shute, P. Venge, and R. Djukanovic
Analysis of fluid{-}phase mediators
Eur. Respir. J., July 1, 2002; 20(37_suppl): 24S - 39s.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Betsuyaku, K. Takeyabu, M. Tanino, and M. Nishimura
Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema
Eur. Respir. J., June 1, 2002; 19(6): 1050 - 1057.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. V. Culpitt, C. de Matos, R. E. Russell, L. E. Donnelly, D. F. Rogers, and P. J. Barnes
Effect of Theophylline on Induced Sputum Inflammatory Indices and Neutrophil Chemotaxis in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1371 - 1376.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M Tanino, T Betsuyaku, K Takeyabu, Y Tanino, E Yamaguchi, K Miyamoto, and M Nishimura
Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema
Thorax, May 1, 2002; 57(5): 405 - 411.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. I. de Boer
Cytokines and Therapy in COPD* : A Promising Combination?
Chest, May 1, 2002; 121(5_suppl): 209S - 218S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P.J. Barnes
Cytokine modulators as novel therapies for airway disease
Eur. Respir. J., July 2, 2001; 18(34_suppl): 67S - 77s.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Johnson and S. Rennard
Alternative Mechanisms for Long-Acting {beta}2-Adrenergic Agonists in COPD
Chest, July 1, 2001; 120(1): 258 - 270.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Gompertz, C. O'Brien, D.L. Bayley, S.L. Hill, and R.A. Stockley
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Eur. Respir. J., June 1, 2001; 17(6): 1112 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. A. D. COOPER Jr., A. L. RIDGEWAY, J. PEARSON, and R. R. CULBRETH
Attenuation of Interleukin 8-induced Nasal Inflammation by an Inhibitor Peptide
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1198 - 1205.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. A. PAUWELS, A. S. BUIST, P. M. A. CALVERLEY, C. R. JENKINS, and S. S. HURD
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease . NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1256 - 1276.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. PILETTE, V. GODDING, R. KISS, M. DELOS, E. VERBEKEN, C. DECAESTECKER, K. DE PAEPE, J.-P. VAERMAN, M. DECRAMER, and Y. SIBILLE
Reduced Epithelial Expression of Secretory Component in Small Airways Correlates with Airflow Obstruction in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 185 - 194.
[Abstract] [Full Text]

Home page
 ThoraxHome page
S Gompertz, D L Bayley, S L Hill, and R A Stockley
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD
Thorax, January 1, 2001; 56(1): 36 - 41.
[Abstract] [Full Text]

Home page
 ThoraxHome page
A. Hill, S. Gompertz, and R. Stockley
Factors influencing airway inflammation in chronic obstructive pulmonary disease
Thorax, November 1, 2000; 55(11): 970 - 977.
[Full Text]

Home page
 NEJMHome page
P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., July 27, 2000; 343(4): 269 - 280.
[Full Text] [PDF]

Home page
 ChestHome page
R. A. Stockley, A. T. Hill, S. L. Hill, and E. J. Campbell
Bronchial Inflammation : Its Relationship to Colonizing Microbial Load and {alpha}1-Antitrypsin Deficiency
Chest, May 1, 2000; 117(5_suppl_1): 291S - 293S.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society